Abstract
The objective of this study is to reveal the relationship between viral load (as HBV DNA) and HBsAg levels. Ninety-two chronically HBV-infected patients were included in the study. The patients were divided in two different groups: the cirrhotic group (n = 32) and the non-cirrhotic group (n = 60). The correlation between study groups was also examined with regard to HBeAg status. Hepatitis B viral markers (HBsAg, HBeAg, Anti-HBs, anti-HBc and anti-HBe) and HBV viral load of the patients were measured. A significant negative correlation between HBV DNA and HBsAg levels was found in the non-cirrhotic group (p < 0.01). The anti-HBc level was higher in the non-cirrhotic group than in the cirrhotic group (p < 0.016). The viral load was significantly higher in HBeAg (+) patients in comparison with HBeAg (−) cases (p < 0.0001). The HBsAg level was low in HBeAg (+) patients, whereas it was higher in HBeAg (−) cases (p < 0.001). In conclusion, a significant negative correlation between viral load and HBsAg levels was detected in the non-cirrhotic chronically HBV-infected group. Therefore, concomitantly low HBsAg and HBV DNA levels may indicate a better prognosis compared to high HBsAg and low HBV DNA levels.
Similar content being viewed by others
References
Tiollais P, Pourcel C, Dejean A (1985) The hepatitis B virus. Nature 317:489–495
Kennedy RC, Ionescu-Matiu I, Alder-Storthz K, Henkel RD, Sanchez Y, Dreesman GR (1983) Characterization of anti-hepatitis B surface antigen monoclonal antibodies. Intervirology 19:176–180
Howard CR, Allison LM (1995) Hepatitis B surface antigen variation and protective immunity. Intervirology 38:35–40
Rehermann B, Manns MP (1996) Immunologic aspects of acute and chronic hepatitis B and C. Curr Opin Gastroenterol 12:554–559
Hong-Yuan H, Mei-Hwei C, Yen-Hsiung L, Shih-Ming W, Ding-Shinn C (1997) Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 26:786–791
Poovorawan Y, Theamboonlers A, Chongsriasawat V, Sanpavat S (1998) Molecular analysis of the a determinant of HBsAg in children of HBeAg-positive mothers upon failure of postexposure prophylaxis. Int J Infect Dis 2:216–220
Feldman M, Scharschmidt BF, Sleisenger MH, Fordtran JS (1998) Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/ management (hardcover). In: Perrillo R, Nair S (eds) Hepatitis B and D, 6th edn, vol 2. WB Saunders, Philadelphia, pp 1130–1135
Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L et al (1990) Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 12(6):1295–1299
Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, et al. (1991) Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119), Hepatology 14(4):581–589
Caldwell SH, Li X, Rourk RM, Millar A, Sosnowski KM, Sue M et al (1993) Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score. Am J Gastroenterol 88(7):1016–1021
Sawada M, Takada A, Takase S, Takada N (1993) Effects of alcohol on the replication of hepatitis C virus. Alcohol Alcohol Suppl 1B:85–90
Xie Y, Zhao H, Dai WS, DZ Xu (2003) HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 2(3):418–422
Lei JH, Yang X, Luo HY, Wang WL, Huang L (2006) Serum HBsAg concentration and HBV replication level in hepatitis B patients with positive serum HBsAg and HBeAg. Zhong Nan Da Xue Xue Bao Yi Xue Ban 31(4):548–551
Deguchi M, Yamashita N, Kagita M, Asari S, Iwatani Y, Tsuchida T et al (2004) Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 115(2):217–222
Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, Brechot C (1993) Persistence of hepatitis B and hepatitis C viral genomees in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 17(1):20–29
Paterlini P, Poussin K, Kew M, Franco D, Brechot C (1995) Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21(2):313–321
Wands JR, Zurawski VR (1981) High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. Gastroenterology 80:225–232
Bhatnagar PK, Papas E, Blum HE, Milich DR, Nitecki D, Kareles MJ et al (1982) Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci USA 79:4400–4404
Strick HJ, Thornton JM, Howard CR (1992) A topological model for hepatitis B surface antigen. Intervitology 33:148–158
Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R et al (1997) The prevalence of surface antigen variants of hepatitis B virus in Papua, New Guinea, South Africa and Sardinia. Hepatology 26:1658–1666
Cooreman MP, Van-Rossmalen MH, Te Morsche R, Sünnen CMG, Schoondermark-van de Ven EME et al (1999) Characterization of the reactivity pattern of murine monoclonal antibodies against wild type hepatitis B surface antigen to G145R and other naturally occurring “a”loop escape mutations. Hepatology 30:1287–1292
Chen WN, Oon CHJ, Toh I (2000) Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common “a” determinant. Am J Gastroenterol 95:1098–1099
Brown JL, Carman WF, Thomas HC (1992) The clinical significance of molecular variation within the hepatitis B virus genomee. Hepatology 15:144–148
Asahina Y, Enomoto N, Ogura Y, Kurosaki M, Sakuma I, Izumi N, Marumo F, Sato C (1996) Sequential changes in full-length genomees of hepatitis B virus accompanying acute exacerbation of chronic hepatitis B. J Hepatol 25:787–794
Weinberger KM, Bauer T, Böhm S, Jilg W (2000) High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 81:1165–1174
Thomas HC, Carman WF (1994) Envelope and precore/core variants of hepatitis B virus. Gastroenterol Clin North Am 23(3):499–514
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ozdil, B., Cosar, A.M., Akkiz, H. et al. Negative correlation between viral load and HBsAg levels in chronic HBV-infected patients. Arch Virol 154, 1451–1455 (2009). https://doi.org/10.1007/s00705-009-0474-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-009-0474-x